Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology

Mostrar otras versiones (1)

BACKGROUND: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) through direct lysis of infected lung epithelial cells, which releases damage-associated molecular patterns and induces a pro-inflammatory cytokine milieu causing systemic inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, No-Joon, Allen, Carter, Vilgelm, Anna E., Riesenberg, Brian P., Weller, Kevin P., Reynolds, Kelsi, Chakravarthy, Karthik B., Kumar, Amrendra, Khatiwada, Aastha, Sun, Zequn, Ma, Anjun, Chang, Yuzhou, Yusuf, Mohamed, Li, Anqi, Zeng, Cong, Evans, John P., Bucci, Donna, Gunasena, Manuja, Xu, Menglin, Liyanage, Namal P. M., Bolyard, Chelsea, Velegraki, Maria, Liu, Shan-Lu, Ma, Qin, Devenport, Martin, Liu, Yang, Zheng, Pan, Malvestutto, Carlos D., Chung, Dongjun, Li, Zihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744064/
https://www.ncbi.nlm.nih.gov/pubmed/35012610
http://dx.doi.org/10.1186/s13045-021-01222-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744064/
https://www.ncbi.nlm.nih.gov/pubmed/35012610
http://dx.doi.org/10.1186/s13045-021-01222-y

Ejemplares similares